NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Similar documents
Management of Opioid Use Disorder in Primary Care

Opioid Use Issues: All the Players

Opiate Use Disorder and Opiate Overdose

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Appendix F Federation of State Medical Boards

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

Opioid Use in Youth. Amy Yule M.D. March 2,

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Acute General Medical and Surgical Admission:

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

2/21/2018. What are Opioids?

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Responding to the Opioid Epidemic: Behavioral Health Specialists Role on the Interprofessional Team

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Hospitals Role in Addressing the Opioid Crisis

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

MAT in the Corrections Setting

Addiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine

History of Present Illness (HPI) Assessment and Plan Template

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Opioids 101. Washington Prevention Summit. Alison Newman, MPH November 6, 2018

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets

Opioid dependence and buprenorphine treatment

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

2004-L SEPTEMBER

Opioid Use Disorder Treatment Initiation in Diverse Settings

Treating Opioid Addiction

Medication Assisted Treatment

What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017

MAT 101: TREATMENT OF OPIOID USE DISORDER

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

HARM REDUCTION & TREATMENT. Devin Reaves MSW

Prescribing drugs of dependence in general practice, Part C

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Treating Opioid Use Disorders: An Update for Counselors and Other Providers

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Opioids Research to Practice

Overdose follow-up interventions:

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Identification and Treatment of Opioid Use Disorders in Primary Care Settings

Opioid Use Disorders &Medication Treatment

Serious Mental Illness and Opioid Use Disorder

MEDICATION-ASSISTED TREATMENT FOR OPIOID USE DISORDER

2/7/2017. Avoid compassion traps. Avoid All or Nothing Traps. Some Explanatory Models of Addiction

Substance Use Disorders

THE STATE OF MEDICINE IN ADDICTION RECOVERY

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Medication Assisted Treatment. Nicole Gastala, MD

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.

Pharmacotherapy for opioid addiction. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION

Building capacity for a CHC response to Ontario's Opioid Crisis

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

Opioid Use Disorder Treatment: Buprenorphine Treatment Basics

Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic

Potential Solutions to Epidemic Substance Abuse in US and Europe

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Fighting Today s Opioid Epidemic

Opioids Research to Practice

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

DPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH

Understanding Medication in Addiction Treatment for Drug Court Participants

Confronting the Opioid Epidemic: Suboxone in Primary Care

The science of the mind: investigating mental health Treating addiction

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

Responding to the Opioid Epidemic

mcmillenhealth.org Linda Hathaway, C.F.C.S.

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

Didactic Series. Opioid Dependence and HIV Care. Theo Katsivas, MD MAS, AAHIVS Associate Clinical Professor Owen Clinic, UCSD 10/25/2018

OUD & MAR: Caring for Our Communities

Clinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder

Medication-Assisted Treatment (MAT) Overview

The Role of the PDMP: Foundational Knowledge and Best Practices

Earl Hightower's Remarks 2014 National Rx Drug Abuse Summit Medication Assisted Treatment for Opiate Addiction

GOALS AND OBJECTIVES

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

BASIC VOLUME. Elements of Drug Dependence Treatment

Safina Koreishi, MD, MPH, Medical Director, Columbia Pacific CCO

AODA RECOVERY. How to support those in recovery, and those not yet ready to commit

Buprenorphine as a Treatment Option for Opioid Use Disorder

Talking with your doctor

MEDICATION ASSISTED TREATMENT

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Reducing opioid overdose mortality: role of communityadministered

Transcription:

NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Opioid Use Disorders Importance of opioid use disorders Screening and DSM-5 definition of substance use disorder Assessment and monitoring in patients prescribed opioids Opioid use disorder treatment with methadone and buprenorphine

Importance of Opioid Use Disorder Common risk factor for HIV infection Youth epidemic of prescription opioid use leading to heroin rural and urban Rising rates of opioid overdose death nationally Complicates management of chronic pain Requires medication-assisted treatment

Screening Screening for drug use not as well developed as for alcohol How many times in the past year have you used an illegal drug or used a prescription medication for non-medical reasons? A positive response is anything but never 100% sensitive, 74% specific for a drug use disorder

DSM-5 Substance Use Disorder 11 Criteria new features in red: - Tolerance (excludes prescribed medication taken as directed) - Withdrawal (excludes prescribed medication taken as directed) - Persistent desire to cut down or quit - Spends lots of time taking, obtaining, recovering - Takes more than intended - Gives up important activities due to substance - Use in spite of physical or psychological problems caused by substance - Failure to fulfill major role obligations due to substance - Recurrent use in physically hazardous situations - Continues use in spite of social or interpersonal problems - Craving (such as strong urge that could not think of anything else)

Assessing Risk: The Opioid Risk Tool Copyright Lynn R. Webster, MD. Used with permission

Getting an Addiction History Establish rapport listen to the pain story Start addiction history by asking about use in the distant past less threatening Assess past problems and treatment efforts Demonstrate support for past efforts to quit Look for a recovery story if problems were severe, there should be one! Past problems + current use = increased risk

Monitoring Patients Prescribed Opioids for Chronic Pain Universal precautions for all patients Includes urine and PMP checks based on risk SUD history and high doses are higher risk Aberrant behaviors can indicate safety issues and require further assessment Do not fire patient, but do make a diagnosis Some patients, especially with high opioid doses, may require addiction treatment

Treating Opioid Use Disorders Patients with Opioid Use Disorder need specialized treatment Methadone maintenance is most effective Patients initially treated with supervised daily doses, counseling, and urine testing Stable patients can get take-home doses Longer duration, higher dose treatment best Maintenance is superior to supported detox

Methadone Maintenance Pearls Ask patients about recent urine test results, take home status, dose trajectory Advise staying in treatment until social, medical, psychiatric, legal and family issues are stable Discuss possibility of extended take home doses as an alternative to tapering off Methadone Maintenance programs may resist accepting pain patients

Buprenorphine for Opioid Use Disorder Federal legislation (DATA 2000) made office based treatment of addiction legal Physicians must complete 8-hour training and obtain a federal waiver Understanding opioid addiction treatment improves chronic pain treatment skills Highly gratifying form of treatment

Full Agonist vs Partial Agonist 100! 90! 80! 70! Full Agonist! Activity! 60! 50! 40! 30! 20! 10! 0! Partial Agonist! Antagonist! -10! -9! -8! -7! -6! -5! -4! Log Dose of Opioid!

Buprenorphine Superior to psychosocial treatment alone Longer treatment duration is more effective Drug use outcomes similar to methadone maintenance treatment, but not as good at retaining patients Some physicians restrict prescribing to patients in their own practice, others accept referrals more widely

Overdose Prevention Overdose education and naloxone is an emerging harm reduction strategy Naloxone reverses opioid overdose For those at high risk of overdose and their friends or family Populations: needle exchange, exit from jail, in drug treatment, high risk prescribed opioids Stopoverdose.org

Opioid Use Disorders Important in HIV management Screening and diagnosis is a key goal Can complicate management of chronic pain Universal precautions is key concept in opioid prescribing for chronic pain Effective treatment is available